Real‐world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load
暂无分享,去创建一个
Q. Bian | Ming Wang | Yunxia Zhu | Hua Zhang | C. Pan | Benjamin Tiongson | Qiumei Pang | Ran Li | Lingzhi Chang | Qian Bian
[1] Noele P. Nelson,et al. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B , 2018, The New England journal of medicine.
[2] Ming Liu,et al. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B , 2018, The American Journal of Gastroenterology.
[3] D. Lu,et al. An expert consensus for the management of chronic hepatitis B in Asian Americans , 2018, Alimentary pharmacology & therapeutics.
[4] [A national survey on physical growth and development of children under seven years of age in nine cities of China in 2015]. , 2018, Zhonghua er ke za zhi = Chinese journal of pediatrics.
[5] James S. Park,et al. Viral factors for HBV mother-to-child transmission , 2017, Hepatology International.
[6] C. Pan,et al. Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B , 2017, Journal of viral hepatitis.
[7] Fengqiong Yang. Prevention of Peripartum Hepatitis B Transmission. , 2016, New England Journal of Medicine.
[8] Shuqin Zhang,et al. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.
[9] Mei-Hwei Chang,et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother‐to‐infant transmission of hepatitis B virus , 2015, Hepatology.
[10] L. Lou,et al. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. , 2015, World journal of gastroenterology.
[11] S. Locarnini,et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. , 2014, Journal of hepatology.
[12] C. Pan,et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. , 2014, Journal of hepatology.
[13] Hua Zhang,et al. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. , 2014, Hepatology.
[14] Z. Duan,et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[15] H. Hsu,et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. , 2013, Journal of hepatology.
[16] C. Pan,et al. Antiviral Therapy for Chronic Hepatitis B in Pregnancy , 2013, Seminars in Liver Disease.
[17] Xiaofeng Liang,et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] K. Reddy,et al. Tenofovir Disoproxil Fumarate for Prevention of Vertical Transmission of Hepatitis B Virus Infection by Highly Viremic Pregnant Women: A Case Series , 2012, Digestive Diseases and Sciences.
[19] Hong Zhang,et al. Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers , 2012, Journal of viral hepatitis.
[20] Wei Zhao,et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.
[21] Wen Chen,et al. Presence of hepatitis B virus in oocytes and embryos: a risk of hepatitis B virus transmission during in vitro fertilization. , 2011, Fertility and sterility.
[22] P. Perumalswami,et al. Pregnancy-related liver diseases. , 2011, Clinics in liver disease.
[23] D. Harnois,et al. Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B , 2011 .
[24] Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data--United States. , 2011, MMWR. Morbidity and mortality weekly report.
[25] Huy Trinh,et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. , 2011, Gastroenterology.
[26] H. Zhuang,et al. [Prevention of hepatitis B virus vertical transmission: current situation and challenges.]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[27] Hung‐Chih Yang,et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.
[28] C. Pan,et al. Revisiting the Natural History of Chronic Hepatitis B in Asian Americans , 2009 .
[29] J. X. Zhang,et al. Natural History and Clinical Consequences of Hepatitis B Virus Infection , 2005, International journal of medical sciences.
[30] W. Fetter,et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. , 1997, Vaccine.
[31] L. Hwang,et al. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. , 1983, The Journal of infectious diseases.